Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller
« Previous
123456789101112
Next »

EU debt crisis adds uncertainty for contract services

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments. CMOs will feel the effect of this in fewer batches and increased pressure to reduce prices.
Jun 1, 2010
By: Jim Miller

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 5, 2010
By: Jim Miller

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 2, 2010
By: Jim Miller

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.
May 1, 2010
By: Jim Miller

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Apr 7, 2010
By: Jim Miller

CMOs' business model has all of the flaws of the captive model it is meant to replace.

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Mar 2, 2010
By: Jim Miller

CMOs' business model has all of the flaws of the captive model it is meant to replace.

A Look Ahead for 2010

Some predictions for contract services in 2010.
Feb 3, 2010
By: Jim Miller

Some predictions for contract services in 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Jan 6, 2010
By: Jim Miller

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

A Look Ahead for 2010

Some predictions for contract services in 2010.
Jan 2, 2010
By: Jim Miller

Some predictions for contract services in 2010.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here